Rituximab safely treated RA patients in long-term follow-up Healio There were 3,194 patients (mean age, 51.5 years; 80.8% women) who had been treated with a maximum of 17 courses of rituximab plus methotrexate (MTX) for up to 9.5 years (all exposure patients; 11,962 patient-years) through September 2011. |
